Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine

Figure 2

Axial views of the patient in Figure 1 with Gleason 3 + 4 disease found in right mid anterior central gland using MRI-TRUS fusion biopsy. The T2 hypointense lesion is shown in (a) with clinical target volumes drawn around the prostate and nodule on axial CT in (b). A 36 Gy dose colorwash to the whole prostate and simultaneous integrated boost of 40 Gy to the T2 hypointense lesion using an extreme hypofractionation radiation treatment plan are shown in (c). Note the fiducial markers used for daily image-guided localization.

(a)

(b)

(c)